ES2524086T3 - Nuevo método para la preparación de ezetimiba - Google Patents
Nuevo método para la preparación de ezetimiba Download PDFInfo
- Publication number
- ES2524086T3 ES2524086T3 ES11738419.8T ES11738419T ES2524086T3 ES 2524086 T3 ES2524086 T3 ES 2524086T3 ES 11738419 T ES11738419 T ES 11738419T ES 2524086 T3 ES2524086 T3 ES 2524086T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- ezetimibe
- preparation
- new method
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 title abstract 3
- 229960000815 ezetimibe Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Método para la preparación de ezetimiba (7) que comprende las siguientes etapas: (a) hacer reaccionar un compuesto de fórmula (1) **Fórmula** donde Ph representa un grupo fenilo y Prot representa un grupo protector de hidroxilos, con una imina de fórmula(2) **Fórmula** para dar una mezcla diastereoisomérica (3a) y (3b) cuyo producto mayoritario es el compuesto de fórmula (3a), **Fórmula**
Description
5
50
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201031052A ES2372460B1 (es) | 2010-07-09 | 2010-07-09 | Nuevo método para la preparación de ezetimiba. |
ES201031052 | 2010-07-09 | ||
PCT/EP2011/061616 WO2012004382A1 (en) | 2010-07-09 | 2011-07-08 | New method for preparing ezetimibe |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2524086T3 true ES2524086T3 (es) | 2014-12-04 |
Family
ID=44532780
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201031052A Expired - Fee Related ES2372460B1 (es) | 2010-07-09 | 2010-07-09 | Nuevo método para la preparación de ezetimiba. |
ES11738419.8T Active ES2524086T3 (es) | 2010-07-09 | 2011-07-08 | Nuevo método para la preparación de ezetimiba |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201031052A Expired - Fee Related ES2372460B1 (es) | 2010-07-09 | 2010-07-09 | Nuevo método para la preparación de ezetimiba. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2590940B1 (es) |
ES (2) | ES2372460B1 (es) |
HR (1) | HRP20141061T1 (es) |
SI (1) | SI2590940T1 (es) |
WO (1) | WO2012004382A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102746249B (zh) * | 2012-07-07 | 2013-12-25 | 山东诚创医药技术开发有限公司 | 一种依折麦布中间体的纯化精制方法 |
CN103450084B (zh) * | 2013-09-09 | 2015-01-28 | 厦门大学 | 除草剂异丙吡草酯的制备方法 |
CN103739537B (zh) * | 2013-12-24 | 2015-05-20 | 连云港恒运医药科技有限公司 | 依折麦布的新合成方法 |
CN103965089B (zh) * | 2014-04-18 | 2016-06-29 | 上海方楠生物科技有限公司 | 一种立体选择性的合成降血脂药物依折麦布的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5739321A (en) | 1996-05-31 | 1998-04-14 | Schering Corporation | 3-hydroxy γ-lactone based enantionselective synthesis of azetidinones |
US6207822B1 (en) * | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
JP3640888B2 (ja) | 1998-12-07 | 2005-04-20 | シェーリング コーポレイション | アゼチジノンの合成プロセス |
JP2001209500A (ja) * | 2000-01-28 | 2001-08-03 | Fujitsu Ltd | ディスク装置およびディスク装置のリード・ライト処理方法 |
BR0116325A (pt) * | 2000-12-21 | 2003-10-14 | Aventis Pharma Gmbh | 1,2-difenilazetidinonas, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação para o tratamento de distúrbios do metabolismo de lipìdios |
DE102005055726A1 (de) * | 2005-11-23 | 2007-08-30 | Sanofi-Aventis Deutschland Gmbh | Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
HU0501164D0 (en) * | 2005-12-20 | 2006-02-28 | Richter Gedeon Vegyeszet | New industrial process for the production of ezetimibe |
DE602006009845D1 (de) | 2005-12-22 | 2009-11-26 | Medichem Sa | Verfahren zur herstellung von zwischenprodukten für die herstellung von ezetimibe |
CZ302395B6 (cs) | 2007-03-02 | 2011-04-27 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
CZ2008317A3 (cs) * | 2008-05-21 | 2009-12-02 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
WO2010141494A2 (en) * | 2009-06-02 | 2010-12-09 | Codexis, Inc. | Synthesis of ezetimibe |
-
2010
- 2010-07-09 ES ES201031052A patent/ES2372460B1/es not_active Expired - Fee Related
-
2011
- 2011-07-08 SI SI201130314T patent/SI2590940T1/sl unknown
- 2011-07-08 EP EP11738419.8A patent/EP2590940B1/en active Active
- 2011-07-08 ES ES11738419.8T patent/ES2524086T3/es active Active
- 2011-07-08 WO PCT/EP2011/061616 patent/WO2012004382A1/en active Application Filing
-
2014
- 2014-11-03 HR HRP20141061AT patent/HRP20141061T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012004382A1 (en) | 2012-01-12 |
ES2372460A1 (es) | 2012-01-20 |
ES2372460B1 (es) | 2012-11-16 |
SI2590940T1 (sl) | 2014-12-31 |
HRP20141061T1 (hr) | 2015-01-02 |
EP2590940A1 (en) | 2013-05-15 |
EP2590940B1 (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501192B1 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
UA108378C2 (uk) | Спосіб одержання плеуромутилінів | |
TN2011000400A1 (en) | Inhibitors of beta-secretase | |
MY193277A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
AU2012324803A8 (en) | (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors | |
NZ630196A (en) | Cyclic amides as metap-2 inhibitors | |
UY33950A (es) | Inhibidores de benzodioxano de la producciòn de leucotrieno | |
SG195118A1 (en) | Process for the production of estetrol intermediates | |
ES2524086T3 (es) | Nuevo método para la preparación de ezetimiba | |
MY172860A (en) | Dimethyl-benzoic acid compounds | |
IN2014MN01521A (es) | ||
BR112014004523A2 (pt) | composto e composição aromatizante | |
EP2575815A4 (en) | GLYCIN TRANSPORTER 1 INHIBITORS, METHODS OF MAKING THE SAME, AND USES THEREOF | |
IN2014DN10617A (es) | ||
BR112013018732A2 (pt) | novos derivados de amida de aril-benzocicloalquila | |
EA201290872A1 (ru) | Способ получения бензоксаборолов | |
BR112013028486A2 (pt) | método para promover crescimento de planta | |
CY1113914T1 (el) | Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν | |
SA516371323B1 (ar) | مركبات بيرازول فلورو فينيل | |
MX343077B (es) | Nuevo derivado de octahidrotienoquinolina, composicion farmaceutica que comprende el derivado, y uso de los mismos. | |
GEP20156234B (en) | Agomelatine intermediates and preparation method thereof | |
IN2014DN10658A (es) | ||
MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
IN2012DE00110A (es) | ||
EA201200267A1 (ru) | Новые соединения дигидрооксазолобензодиазепинона, способ их получения и фармацевтические композиции, их содержащие |